ZYNLONTA

Serial Number 97571349
Registration 7403110
700

Registration Progress

Application Filed
Aug 30, 2022
Under Examination
Sep 12, 2023
Approved for Publication
Jul 18, 2023
Published for Opposition
Jul 18, 2023
Registered
May 28, 2024

Trademark Image

ZYNLONTA

Basic Information

Serial Number
97571349
Registration Number
7403110
Filing Date
August 30, 2022
Registration Date
May 28, 2024
Published for Opposition
July 18, 2023
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
May 28, 2024
Registration
Registered
Classes
005 044

Rights Holder

ADC Therapeutics SA

99
Address
Route de la Corniche, 3B
Epalinges 1066
CH

Ownership History

ADC Therapeutics SA

Original Applicant
99
Epalinges CH

ADC Therapeutics SA

Owner at Publication
99
Epalinges CH

ADC Therapeutics SA

Original Registrant
99
Epalinges CH

Legal Representation

Attorney
Tracy-Gene G. Durkin

USPTO Deadlines

Next Deadline
1761 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-05-28)
Due Date
May 28, 2030
Grace Period Ends
November 28, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

18 events
Date Code Type Description Documents
May 28, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 28, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Apr 25, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Apr 25, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Apr 2, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Apr 2, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Mar 11, 2024 IUAF S USE AMENDMENT FILED Loading...
Mar 11, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Sep 12, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 18, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 18, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 28, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 15, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 15, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 1, 2023 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Sep 20, 2022 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Sep 18, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 2, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology
First Use Anywhere: Dec 6, 2023
First Use in Commerce: Dec 6, 2023
Class 044
Providing medical information; providing information in the fields of healthcare, therapeutic properties of pharmaceuticals, and health
First Use Anywhere: May 11, 2021
First Use in Commerce: May 11, 2021

Additional Information

Design Mark
The mark consists of the wording "Zynlonta" followed by a design having three bars extending from a central diamond, with a smaller diamond positioned at the end of each bar, and a circle that intersects all three bars.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005 044